QUMAS, provider of enterprise compliance management solutions for the life sciences industry, has launched its newest product, QUMAS Visa, designed to help pharmaceutical, medical device, and biotechnology corporations comply with the latest international regulations. QUMAS Visa is a secure, Web-based viewing client for the firm's flagship product, e-DocCompliance, a Web-based application that manages the full life cycle of regulatory-controlled documentation in compliance with FDA, EMEA, ISO, and other international regulations. Key features of QUMAS Visa include: a security model that provides tight control of user privileges to ensure appropriate document access; a light desktop client which requires minimal desktop resources, installation, validation and support; a 21 CFR Part 11-compliant which captures all viewing and print activities in a secure, independently-generated audit trail; controlled document printing and watermarking enables authorized users to print hard copies of controlled documents; e-mail and inbox notification function informs users when key documents change, and when new versions of documents become available; and rapid access, search and retrieval capabilities that enable users to access the most accurate and up-to-date information quickly and easily. QUMAS Visa leverages J2EE and XML to seamlessly integrate with existing technology infrastructures, enabling life sciences organizations to maximize the value of existing technology investments. QUMAS Visa is now available for purchase, with pricing dependent on the size and scope of implementation.